Innovaderm ResearchThe Intricacies of Multicenter Studies in Alopecia AreataAlopecia Areata: The ConditionJun 21Jun 21
Innovaderm ResearchEurope: Global Clinical Trial Activity’s Prime LocationThe European Union (EU) is listed as one of the most desirable regions to conduct a clinical trial and Innovaderm has positioned itself as…Jun 20Jun 20
Innovaderm ResearchAtopy and Alopecia Areata: A Leading PairAlopecia areata (AA) and atopy, which is a predisposition to develop allergic reactions, share a significant connection. While thyroid…Jun 20Jun 20
Innovaderm ResearchBreakthrough Therapies for Alopecia AreataAlopecia Areata (AA) is a condition characterized by unpredictable hair loss. The precise trigger of this immune response remains elusive…Jun 18Jun 18
Innovaderm Research3 Tips on Protocol Writing from an Investigator’s PerspectiveThe success of any clinical study is dependent upon a sturdy protocol; the overall quality of the study depends on this very document. This…Jun 14Jun 14
Innovaderm ResearchDr. Robert Bissonnette and Dr. Kim Papp on Alopecia Areata InsightsIn collaboration with Probity Medical Research (PMR)Apr 8Apr 8
Innovaderm ResearchDr. Robert Bissonnette and Dr. Kim Papp on Navigating the Challenges of Vitiligo Research TrialsIn collaboration with Probity Medical Research (PMR)Apr 8Apr 8
Innovaderm ResearchDr. Robert Bissonnette and Dr.In collaboration with Probity Medical Research (PMR)Apr 8Apr 8
Innovaderm ResearchDr. Robert Bissonnette and Dr. Kim Papp on Shaping the Future of Clinical ResearchIn collaboration with Probity Medical Research (PMR)Apr 8Apr 8
Innovaderm ResearchHow to Write First-Rate Protocols for an Acne Vulgaris Clinical Trial: Best tips for developing…In recent years, dermatologic therapeutics has become a subspecialty of growing interest in the CRO industry, with clinical research in the…Apr 4Apr 4
